Immunoprecise Antibodies Ltd
IPA2.070USD
0.000
Handelsschluss 11/04, 16:00（ET）Kurse um 15 Minuten verzögert
95.54MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Immunoprecise Antibodies Ltd Unternehmen
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Immunoprecise Antibodies Ltd Informationen
BörsenkürzelIPA
Name des UnternehmensImmunoprecise Antibodies Ltd
IPO-datumJan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeJan 30
AddresseIndustrious 823 Congress Ave Suite 300
StadtAUSTIN
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl78701
Telefon16048060626
Websitehttps://www.ipatherapeutics.com/
BörsenkürzelIPA
IPO-datumJan 30, 1987
CEODr. Jennifer Lynne Bath, Ph.D.
Führungskräfte von Immunoprecise Antibodies Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Director
Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Dr. Ilse Roodink, Ph.D.
Dr. Ilse Roodink, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Barry A. Springer
Mr. Barry A. Springer
Independent Director
Independent Director
--
--
Mr. Joseph Scheffler
Mr. Joseph Scheffler
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jennifer Lynne Bath, Ph.D.
Dr. Jennifer Lynne Bath, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
498.12K
--
Dr. Kamil Isaev
Dr. Kamil Isaev
Director
Director
3.19K
--
Mr. Dirk Witters
Mr. Dirk Witters
Independent Director
Independent Director
1.95K
--
Ms. Kari Graber
Ms. Kari Graber
Vice President - Commercial Services
Vice President - Commercial Services
700.00
--
Mr. Jonathan I. (Jon) Lieber
Mr. Jonathan I. (Jon) Lieber
Director
Director
--
--
Dr. Ilse Roodink, Ph.D.
Dr. Ilse Roodink, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Project revenue
3.13M
98.89%
Cryo storage revenue
33.00K
1.04%
Product sales revenue
2.00K
0.06%
Nach RegionUSD
Name
Umsatz
Anteil
United States of America
2.45M
77.48%
Europe
520.00K
16.45%
Canada
174.00K
5.50%
Australia
18.00K
0.57%
Other
0.00
0.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Project revenue
3.13M
98.89%
Cryo storage revenue
33.00K
1.04%
Product sales revenue
2.00K
0.06%
Aktionärsstatistik
Aktualisiert: Sun, Sep 14
Aktualisiert: Sun, Sep 14
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Charmquark TWEE
7.92%
Ingalls & Snyder LLC (Asset Management)
6.02%
Susquehanna International Group, LLP
1.51%
Bath (Jennifer Lynne)
1.08%
XTX Markets LLC
0.20%
Andere
83.26%
Aktionäre
Aktionäre
Anteil
Charmquark TWEE
7.92%
Ingalls & Snyder LLC (Asset Management)
6.02%
Susquehanna International Group, LLP
1.51%
Bath (Jennifer Lynne)
1.08%
XTX Markets LLC
0.20%
Andere
83.26%
Aktionärstypen
Aktionäre
Anteil
Corporation
7.92%
Investment Advisor/Hedge Fund
6.11%
Investment Advisor
1.71%
Individual Investor
1.23%
Research Firm
0.30%
Hedge Fund
0.28%
Venture Capital
0.20%
Family Office
0.04%
Andere
82.21%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
40
3.97M
8.60%
-183.07K
2025Q2
46
8.16M
23.11%
+1.40M
2025Q1
45
6.32M
13.81%
+742.61K
2024Q4
45
4.34M
9.53%
-1.30M
2024Q3
46
5.39M
19.68%
+72.87K
2024Q2
48
5.12M
19.96%
-156.62K
2024Q1
50
5.14M
20.20%
-196.19K
2023Q4
58
5.33M
20.96%
+124.72K
2023Q3
50
4.91M
19.67%
-438.42K
2023Q2
53
5.01M
20.08%
-885.29K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Charmquark TWEE
3.66M
7.92%
--
--
Jul 25, 2025
Ingalls & Snyder LLC (Asset Management)
2.78M
6.02%
+21.24K
+0.77%
Jun 30, 2025
Susquehanna International Group, LLP
699.24K
1.51%
-3.76K
-0.53%
Jun 30, 2025
Bath (Jennifer Lynne)
498.12K
1.08%
--
--
Aug 27, 2025
XTX Markets LLC
91.38K
0.2%
+72.90K
+394.36%
Jun 30, 2025
Two Sigma Investments, LP
90.86K
0.2%
+273.00
+0.30%
Jun 30, 2025
CIBC World Markets Inc.
41.20K
0.09%
--
--
Jun 30, 2025
Renaissance Technologies LLC
40.48K
0.09%
+11.08K
+37.69%
Jun 30, 2025
Levine (Mitchell S)
30.00K
0.07%
+10.00K
+50.00%
Aug 01, 2024
Virtu Americas LLC
28.92K
0.06%
-28.92K
-50.00%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Name
Anteil
Keine Daten
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
